invivomab α il 12 blocking antibody
(Bio X Cell)
Bio X Cell is a verified supplier
Bio X Cell manufactures this product
Structured Review
Bio X Cell
invivomab α il 12 blocking antibody
Invivomab α Il 12 Blocking Antibody, supplied by Bio X Cell, used in various techniques. Bioz Stars score: 94/100, based on 21 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and morehttps://www.bioz.com/product/invivomab+%CE%B1+il+12+blocking+antibody/InVivoMAb+anti-mouse+IL-12+p75/pmc12048687-39-0-5
Average 94 stars, based on 21 article reviews
invivomab α il 12 blocking antibody - by
Bioz Stars,
2026-09
94/100 stars
Images
1) Product Images from "T-cell-derived IFN-γ suppresses T follicular helper cell differentiation and antibody responses"
Article Title: T-cell-derived IFN-γ suppresses T follicular helper cell differentiation and antibody responses
Journal: The EMBO Journal
doi: 10.1038/s44318-025-00414-3
Figure Legend Snippet: Reagents and tools table
Techniques Used: Transgenic Assay, Mouse Assay, Recombinant, Blocking Assay, Control, Staining, Sequencing, Expressing, Derivative Assay, Lysis, Software, Cell Isolation, Microscopy, Real-time Polymerase Chain Reaction
Related Articles
Blocking Assay:Article Title: T cell-derived IFN-γ Suppresses T Follicular Helper Cell Differentiation and Antibody Responses during Viral Infections
Article Snippet: .. In indicated experiments, mice were treated with: InVivoMab α-IFN-γ blocking antibody (BioXcell Clone XMG1.2 #BE0055) or rat IgG1 isotype control (BioXcell Clone HRPN #BE0088): 250 μg intraperitoneally (i.p.) at day 0 (or in selected experiments at day 3); InVivoMab α-IL-12 blocking antibody (BioXcell Clone R2-9A5 #BE0233) or rat IgG2b isotype control, (BioXcell Clone LFT-2 #BE0090): 1 mg i.p. at day 0 and 3 after infection; InVivoMab α-NK1.1 depleting antibody (BioXcell Clone PK136 #BE0036): 1 mg i.p. at day 0 and day 1 after infection; InVivoMab α-CD8 depleting antibody (BioXcell Clone YTS 169.4 #BE0117): 200 μg i.p. at day -1 and day 2 after infection. .. To deplete DCs 500 ng of diphtheria toxin (DTX, Millipore, #322326) diluted in 200μl of PBS was administered i.p. one day before the infection and every other day thereafter to CD11c-DTR/IFN-γ -/- and CD11c-DTR/WT BM chimeras, respectively.
Article Title: T-cell-derived IFN-γ suppresses T follicular helper cell differentiation and antibody responses
Article Snippet: .. In indicated experiments, mice were treated with: InVivoMab α-IFN-γ blocking antibody (BioXcell Clone XMG1.2 #BE0055) or rat IgG1 isotype control (BioXcell Clone HRPN #BE0088): 250 μg intraperitoneally (i.p.) at day 0 (or in selected experiments at day 3); InVivoMab α-IL-12 blocking antibody (BioXcell Clone R2-9A5 #BE0233) or rat IgG2b isotype control, (BioXcell Clone LFT-2 #BE0090): 1 mg i.p. at day 0 and 3 after infection; InVivoMab α-NK1.1 depleting antibody (BioXcell Clone PK136 #BE0036): 1 mg i.p. at day 0 and day 1 after infection; InVivoMab α-CD8 depleting antibody (BioXcell Clone YTS 169.4 #BE0117): 200 μg i.p. at day −1 and day 2 after infection. .. To deplete DCs 500 ng of diphtheria toxin (DTX, Millipore, #322326) diluted in 200 μl of PBS was administered i.p. one day before the infection and every other day thereafter to CD11c-DTR/IFN-γ −/− and CD11c-DTR/WT BM chimeras, respectively.
Control:Article Title: T cell-derived IFN-γ Suppresses T Follicular Helper Cell Differentiation and Antibody Responses during Viral Infections
Article Snippet: .. In indicated experiments, mice were treated with: InVivoMab α-IFN-γ blocking antibody (BioXcell Clone XMG1.2 #BE0055) or rat IgG1 isotype control (BioXcell Clone HRPN #BE0088): 250 μg intraperitoneally (i.p.) at day 0 (or in selected experiments at day 3); InVivoMab α-IL-12 blocking antibody (BioXcell Clone R2-9A5 #BE0233) or rat IgG2b isotype control, (BioXcell Clone LFT-2 #BE0090): 1 mg i.p. at day 0 and 3 after infection; InVivoMab α-NK1.1 depleting antibody (BioXcell Clone PK136 #BE0036): 1 mg i.p. at day 0 and day 1 after infection; InVivoMab α-CD8 depleting antibody (BioXcell Clone YTS 169.4 #BE0117): 200 μg i.p. at day -1 and day 2 after infection. .. To deplete DCs 500 ng of diphtheria toxin (DTX, Millipore, #322326) diluted in 200μl of PBS was administered i.p. one day before the infection and every other day thereafter to CD11c-DTR/IFN-γ -/- and CD11c-DTR/WT BM chimeras, respectively.
Article Title: T-cell-derived IFN-γ suppresses T follicular helper cell differentiation and antibody responses
Article Snippet: .. In indicated experiments, mice were treated with: InVivoMab α-IFN-γ blocking antibody (BioXcell Clone XMG1.2 #BE0055) or rat IgG1 isotype control (BioXcell Clone HRPN #BE0088): 250 μg intraperitoneally (i.p.) at day 0 (or in selected experiments at day 3); InVivoMab α-IL-12 blocking antibody (BioXcell Clone R2-9A5 #BE0233) or rat IgG2b isotype control, (BioXcell Clone LFT-2 #BE0090): 1 mg i.p. at day 0 and 3 after infection; InVivoMab α-NK1.1 depleting antibody (BioXcell Clone PK136 #BE0036): 1 mg i.p. at day 0 and day 1 after infection; InVivoMab α-CD8 depleting antibody (BioXcell Clone YTS 169.4 #BE0117): 200 μg i.p. at day −1 and day 2 after infection. .. To deplete DCs 500 ng of diphtheria toxin (DTX, Millipore, #322326) diluted in 200 μl of PBS was administered i.p. one day before the infection and every other day thereafter to CD11c-DTR/IFN-γ −/− and CD11c-DTR/WT BM chimeras, respectively.
Infection:Article Title: T cell-derived IFN-γ Suppresses T Follicular Helper Cell Differentiation and Antibody Responses during Viral Infections
Article Snippet: .. In indicated experiments, mice were treated with: InVivoMab α-IFN-γ blocking antibody (BioXcell Clone XMG1.2 #BE0055) or rat IgG1 isotype control (BioXcell Clone HRPN #BE0088): 250 μg intraperitoneally (i.p.) at day 0 (or in selected experiments at day 3); InVivoMab α-IL-12 blocking antibody (BioXcell Clone R2-9A5 #BE0233) or rat IgG2b isotype control, (BioXcell Clone LFT-2 #BE0090): 1 mg i.p. at day 0 and 3 after infection; InVivoMab α-NK1.1 depleting antibody (BioXcell Clone PK136 #BE0036): 1 mg i.p. at day 0 and day 1 after infection; InVivoMab α-CD8 depleting antibody (BioXcell Clone YTS 169.4 #BE0117): 200 μg i.p. at day -1 and day 2 after infection. .. To deplete DCs 500 ng of diphtheria toxin (DTX, Millipore, #322326) diluted in 200μl of PBS was administered i.p. one day before the infection and every other day thereafter to CD11c-DTR/IFN-γ -/- and CD11c-DTR/WT BM chimeras, respectively.
Article Title: T-cell-derived IFN-γ suppresses T follicular helper cell differentiation and antibody responses
Article Snippet: .. In indicated experiments, mice were treated with: InVivoMab α-IFN-γ blocking antibody (BioXcell Clone XMG1.2 #BE0055) or rat IgG1 isotype control (BioXcell Clone HRPN #BE0088): 250 μg intraperitoneally (i.p.) at day 0 (or in selected experiments at day 3); InVivoMab α-IL-12 blocking antibody (BioXcell Clone R2-9A5 #BE0233) or rat IgG2b isotype control, (BioXcell Clone LFT-2 #BE0090): 1 mg i.p. at day 0 and 3 after infection; InVivoMab α-NK1.1 depleting antibody (BioXcell Clone PK136 #BE0036): 1 mg i.p. at day 0 and day 1 after infection; InVivoMab α-CD8 depleting antibody (BioXcell Clone YTS 169.4 #BE0117): 200 μg i.p. at day −1 and day 2 after infection. .. To deplete DCs 500 ng of diphtheria toxin (DTX, Millipore, #322326) diluted in 200 μl of PBS was administered i.p. one day before the infection and every other day thereafter to CD11c-DTR/IFN-γ −/− and CD11c-DTR/WT BM chimeras, respectively.
|